{"date":"2026-07-15","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7799-2026-07-15-2020-77mdg4","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-07-15","time":"20:20:16","subject":"本公司研發之B10 L-BPA注射液術前輔助治療局部晚期口腔癌之第一及第二期學術研究用人體臨床試驗，通過台灣衛生福利部食品藥物管理署(TFDA)新藥臨床試驗(IND)審查","clause":"第10款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-07-15 20:20，「本公司研發之B10 L-BPA注射液術前輔助治療局部晚期口腔癌之第一及第二期學術研究用人體臨床試驗，通過台灣衛生福利部食」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-07-15-2008-virc3b","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"20:08:57","subject":"代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright &Co.投資銀行舉辦之第六屆眼科線上年會(H.C. Wainwright 6thAnnual Ophthalmology Virtual Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-07-15 20:08，「代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright &Co.投資銀行舉辦之第六屆眼科線」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-07-15-1919-va6al","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"19:19:18","subject":"公告本公司115年6月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-07-15 19:19，「公告本公司115年6月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-07-15-1914-3qrgck","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-07-15","time":"19:14:43","subject":"公告本公司決議現金股利配息基準日(補充說明115/07/03及115/07/06 公告)","clause":"第14款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-07-15 19:14，「公告本公司決議現金股利配息基準日(補充說明115/07/03及115/07/06 公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-07-15-1825-13rpxz5","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"18:25:06","subject":"公告本公司訂定除息基準日等相關事宜","clause":"第31款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-07-15 18:25，「公告本公司訂定除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-07-15-1820-v1gwxu","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"18:20:55","subject":"公告本公司調整現金股利配息率","clause":"第31款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-07-15 18:20，「公告本公司調整現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-07-15-1735-xxncdu","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"17:35:00","subject":"更正公告本公司及代子公司Handa Pharma, Inc.及HandaOncology, LLC公告505(b)(2)新藥HND-039美國專利訴訟案之相關文書案號","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-07-15 17:35，「更正公告本公司及代子公司Handa Pharma, Inc.及HandaOncology, LLC公告505(b)(2)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-07-15-1730-1dts663","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"17:30:21","subject":"公告本公司內部稽核主管異動事宜","clause":"第8款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-07-15 17:30，「公告本公司內部稽核主管異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-07-15-1728-5rh607","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"17:28:51","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-07-15 17:28，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-07-15-1727-1oixrch","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"17:27:03","subject":"公告本公司發言人異動事宜","clause":"第8款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-07-15 17:27，「公告本公司發言人異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-07-15-1725-gey8f1","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"17:25:25","subject":"公告本公司總經理異動事宜","clause":"第6款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-07-15 17:25，「公告本公司總經理異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-07-15-1715-i7ulva","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"17:15:54","subject":"公告修正本公司114年度年報部份內容。","clause":"第44款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-07-15 17:15，「公告修正本公司114年度年報部份內容。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-07-15-1628-ygu86e","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"16:28:43","subject":"本公司受邀參加由證券櫃檯買賣中心與富邦證券合作舉辦之亞洲生技大展法人說明會","clause":"第30款","fact_date":"2026-07-16","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-07-15 16:28，「本公司受邀參加由證券櫃檯買賣中心與富邦證券合作舉辦之亞洲生技大展法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-07-15-1627-11xio6h","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"16:27:36","subject":"本公司受邀參加2026年櫃買中心暨富邦證券舉辦之生技產業論壇","clause":"第12款","fact_date":"2026-07-16","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-07-15 16:27，「本公司受邀參加2026年櫃買中心暨富邦證券舉辦之生技產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-07-15-1614-1cccuo4","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"16:14:49","subject":"公告本公司董事長訂定除息基準日","clause":"第31款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-07-15 16:14，「公告本公司董事長訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-07-15-1601-7bbsxj","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-07-15","time":"16:01:17","subject":"本公司受邀參加櫃買中心及富邦證券舉辦之生技產業論壇","clause":"第30款","fact_date":"2026-07-16","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-07-15 16:01，「本公司受邀參加櫃買中心及富邦證券舉辦之生技產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-07-15-1541-1jfvhev","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"15:41:51","subject":"公告本公司新增資金貸與金額達新臺幣一千萬元以上且達本公司最近期財務報表淨值百分之二以上","clause":"第23款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-07-15 15:41，「公告本公司新增資金貸與金額達新臺幣一千萬元以上且達本公司最近期財務報表淨值百分之二以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-07-15-1525-1nxb0oo","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-07-15","time":"15:25:46","subject":"因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-07-15 15:25，「因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-07-15-1523-1igyjof","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-07-15","time":"15:23:33","subject":"公告本公司洽定上櫃買賣開始日並自同日起終止興櫃買賣","clause":"第28款","fact_date":"2026-07-15","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-07-15 15:23，「公告本公司洽定上櫃買賣開始日並自同日起終止興櫃買賣」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}